Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
49
NMPA:49
Drug Approvals
Paracetamol Effervescent Granules
- Product Name
- 对乙酰氨基酚泡腾颗粒
- Approval Number
- 国药准字H20003758
- Approval Date
- Jul 7, 2020
NMPA
Ranitidine Hydrochloride Capsules
- Product Name
- 盐酸雷尼替丁胶囊
- Approval Number
- 国药准字H19983218
- Approval Date
- May 25, 2020
NMPA
Aminopyrine and Coffine Tablets
- Product Name
- 氨基比林咖啡因片
- Approval Number
- 国药准字H13024006
- Approval Date
- May 25, 2020
NMPA
Sulfamethoxazole，Sulfadiazine and Trimethoprim Tablets
- Product Name
- 联磺甲氧苄啶片
- Approval Number
- 国药准字H13020297
- Approval Date
- May 25, 2020
NMPA
Compound Sulfamethoxazole Tablets
- Product Name
- 复方磺胺甲噁唑片
- Approval Number
- 国药准字H13020296
- Approval Date
- May 25, 2020
NMPA
Aspirin Enteric-coated Tablets
- Product Name
- 阿司匹林肠溶片
- Approval Number
- 国药准字H19994130
- Approval Date
- May 25, 2020
NMPA
Erythromycin Ethylsuccinate Granules
- Product Name
- 琥乙红霉素颗粒
- Approval Number
- 国药准字H20003035
- Approval Date
- May 25, 2020
NMPA
Pediatric Compound Sulfamethoxazole Granules
- Product Name
- 小儿复方磺胺甲噁唑颗粒
- Approval Number
- 国药准字H13024008
- Approval Date
- May 25, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
No trials found
News
No news found